Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Opioid Induced Constipation (OIC) Drugs Market Research Report 2020 by Manufacturers, Regions, Types and Applications

  • RnM3855445
    • |
  • 03 August, 2020
    • |
  • Global
    • |
  • 110 Pages
    • |
  • XYZResearch
    • |
  • Medical Devices & Consumables

According to XYZResearch study, over the next five years the Opioid Induced Constipation (OIC) Drugsmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Opioid Induced Constipation (OIC) Drugsbusiness.
Opioid Induced Constipation (OIC) Drugs market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

Global Opioid Induced Constipation (OIC) Drugs market competition by top manufacturers/players, with Opioid Induced Constipation (OIC) Drugs sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Opioid Induced Constipation (OIC) Drugs for each application, including
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Feel free to let me know if you have any special requirements.


Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Opioid Induced Constipation (OIC) Drugs Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Lubiprostone
      • 2.1.2 Methyl Naltrexone Bromide
      • 2.1.3 Naldemedine
      • 2.1.4 Alvimopan
      • 2.1.5 Other
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Lubiprostone
      • 2.2.2 Methyl Naltrexone Bromide
      • 2.2.3 Naldemedine
      • 2.2.4 Alvimopan
      • 2.2.5 Other

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospital Pharmacies
      • 3.1.2 Retail Pharmacies
      • 3.1.3 Online Pharmacies

    4 Manufacturers Profiles/Analysis

    • 4.1 Ironwood Pharmaceuticals Inc
      • 4.1.1 Ironwood Pharmaceuticals Inc Profiles
      • 4.1.2 Ironwood Pharmaceuticals Inc Product Information
      • 4.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Ironwood Pharmaceuticals Inc SWOT Analysis
    • 4.2 Daiichi Sankyo Co Ltd
      • 4.2.1 Daiichi Sankyo Co Ltd Profiles
      • 4.2.2 Daiichi Sankyo Co Ltd Product Information
      • 4.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 Daiichi Sankyo Co Ltd SWOT Analysis
    • 4.3 Pfizer
      • 4.3.1 Pfizer Profiles
      • 4.3.2 Pfizer Product Information
      • 4.3.3 Pfizer Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Pfizer SWOT Analysis
    • 4.4 Progenics Pharmaceuticals Inc
      • 4.4.1 Progenics Pharmaceuticals Inc Profiles
      • 4.4.2 Progenics Pharmaceuticals Inc Product Information
      • 4.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Progenics Pharmaceuticals Inc SWOT Analysis
    • 4.5 Shionogi & Co., Ltd
      • 4.5.1 Shionogi & Co., Ltd Profiles
      • 4.5.2 Shionogi & Co., Ltd Product Information
      • 4.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 Shionogi & Co., Ltd SWOT Analysis
    • 4.6 Allergan Plc
      • 4.6.1 Allergan Plc Profiles
      • 4.6.2 Allergan Plc Product Information
      • 4.6.3 Allergan Plc Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Allergan Plc SWOT Analysis
    • 4.7 Nektar Therapeutics
      • 4.7.1 Nektar Therapeutics Profiles
      • 4.7.2 Nektar Therapeutics Product Information
      • 4.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Nektar Therapeutics SWOT Analysis
    • 4.8 Purdue Pharma
      • 4.8.1 Purdue Pharma Profiles
      • 4.8.2 Purdue Pharma Product Information
      • 4.8.3 Purdue Pharma Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Purdue Pharma SWOT Analysis
    • 4.9 S.L.A. Pharma AG
      • 4.9.1 S.L.A. Pharma AG Profiles
      • 4.9.2 S.L.A. Pharma AG Product Information
      • 4.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 S.L.A. Pharma AG SWOT Analysis
    • 4.10 Mundipharma International Limited
      • 4.10.1 Mundipharma International Limited Profiles
      • 4.10.2 Mundipharma International Limited Product Information
      • 4.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Mundipharma International Limited SWOT Analysis
    • 4.11 Ono Pharmaceutical Co., Ltd
    • 4.12 Takeda Pharmaceutical Company Limited
    • 4.13 Theravance Biopharma Inc
    • 4.14 Valeant Pharmaceuticals International
    • 4.15 Cosmo Pharmaceuticals SA
    • 4.16 Daewoong Pharmaceutical
    • 4.17 C.B. Fleet Company
    • 4.18 Sucampo Pharmaceuticals

    5 Market Performance for Manufacturers

    • 5.1 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Opioid Induced Constipation (OIC) Drugs Market Assessment by Regions (2014-2020)

    • 7.1 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Opioid Induced Constipation (OIC) Drugs Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Hospital Pharmacies Industry
    • 11.2 Retail Pharmacies Industry
    • 11.3 Online Pharmacies Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Lubiprostone
      • 12.2.3 Methyl Naltrexone Bromide
      • 12.2.4 Naldemedine
      • 12.2.5 Alvimopan
      • 12.2.6 Other
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Hospital Pharmacies
      • 12.3.3 Retail Pharmacies
      • 12.3.4 Online Pharmacies
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Opioid Induced Constipation (OIC) Drugs Gross Profit Trend 2021-2026

    13 Conclusion

    Summary:
    Get latest Market Research Reports on Opioid Induced Constipation (OIC) Drugs. Industry analysis & Market Report on Opioid Induced Constipation (OIC) Drugs is a syndicated market report, published as Global Opioid Induced Constipation (OIC) Drugs Market Research Report 2020 by Manufacturers, Regions, Types and Applications. It is complete Research Study and Industry Analysis of Opioid Induced Constipation (OIC) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,650.00
    		$7,200.00
    		2,909.05
    		5,738.40
    		3,390.85
    		6,688.80
    		558,194.50
    		1,101,096.00
    		304,483.00
    		600,624.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo